Saturday 17 October 2026
Export WEAV’s income statement to Excel — free account
Weave Communications, Inc.
WEAV Healthcare Health Information Services
Weave Communications, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $239.0 million, up 17.0% from fiscal 2024. In the quarter to June 2026, revenue grew 15.5%, EPS grew 54.6%, free cash flow grew 94.3% and total debt rose 4.91%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
7.39
0.00
0.00%
Follow WEAV
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
2.25 | 2.42 | 1.46 | 1.85 | |
P/FCF ratio |
35.41 | 45.04 | 53.40 | 43.28 | |
P/Operating CF |
85.13 | 92.74 | (63.63) | 46.58 | |
P/B ratio |
6.57 | 7.03 | 4.36 | 5.61 | |
Price to Tangible BV |
12.40 | 12.65 | 7.72 | 9.72 | |
EV/Sales |
1.97 | 2.15 | 1.23 | 1.61 | |
EV/EBITDA |
0.00 | 0.00 | 65.79 | 35.22 | |
EV/Operating CF |
25.19 | 29.29 | 25.44 | 24.68 | |
EV/FCF |
31.03 | 39.94 | 45.11 | 37.72 | |
Quick Ratio |
1.02 | 1.02 | 0.95 | 0.99 | |
Current Ratio |
1.24 | 1.24 | 1.24 | 1.25 | |
Net Debt/EBITDA |
70.09 | (12.59) | (26.88) | (16.21) | |
Debt/Assets |
3.07% | 3.00% | 3.12% | 3.48% | |
Debt/Equity |
0.08 | 0.08 | 0.08 | 0.09 | |
Asset Turnover |
1.15 | 1.20 | 1.27 | 1.25 | |
Operating CF/Net income |
(0.70) | (3.38) | 0.99 | (2.41) | |
Capex/Depreciation |
(0.13) | (0.23) | (0.17) | (0.18) | |
Interest Coverage |
(24.44) | (5.40) | (16.32) | (10.44) | |
Research and Development Expense of Revenue |
21.39% | 12.93% | 16.51% | 17.85% | |
Selling, General and Administrative Expense of Revenue |
65.48% | 63.14% | 65.26% | 60.68% | |
Intangible Assets out of Total Assets |
0.18 | 0.18 | 0.18 | 0.17 | |
Share Based Compensation of Revenue |
16.17% | 6.26% | 10.89% | 10.41% | |
Graham Net Nets |
(0.05) | (0.04) | (0.06) | (0.04) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(6.44%) | (4.74%) | (6.71%) | (4.17%) | |
Free Cash Flow Yield |
2.82% | 2.22% | 1.87% | 2.31% | |
Revenue per Share |
0.79 | 0.83 | 0.83 | 0.85 | |
Operating CF per Share |
0.08 | 0.08 | (0.07) | 0.13 | |
Capex per Share |
(0.01) | (0.02) | (0.02) | (0.02) | |
Free Cash Flow per Share |
0.07 | 0.06 | (0.09) | 0.11 | |
Cash per Share |
1.04 | 1.07 | 0.93 | 0.99 | |
Shareholders Equity per Share |
1.02 | 1.08 | 1.06 | 1.07 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.02 | 1.08 | 1.06 | 1.07 | |
Free Cash Flow |
5.05 | 4.40 | (7.12) | 8.70 | |
Working Capital |
20.04 | 20.40 | 19.61 | 20.73 | |
Capital Expenditures |
(1.02) | (1.85) | (1.42) | (1.54) | |
Net Current Asset Value |
(24.89) | (20.59) | (20.33) | (18.91) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.03 | 0.02 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
6.32 | 4.05 | 3.88 | 3.92 | |
Average Payables |
6.86 | 7.77 | 5.74 | 7.01 | |
Average Assets |
199.25 | 198.45 | 196.30 | 206.47 | |
Average Common Equity |
73.73 | 74.68 | 75.93 | 81.92 |
Columns are period end dates